Stephan Harbarth earned in 1993 his medical degree from Ludwig-Maximilians-University in Munich, Germany, and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard University in Boston. He is board certified in infectious diseases and was appointed full professor at the University of Geneva in 2018. Dr Harbarth’s work has garnered several awards. His group is currently conducting several clinical and epidemiological studies to evaluate key questions related to the control of the acquisition, transmission and infection by multidrug-resistant microorganisms and related clinical and health-economic burden. He participates in several ongoing large-scale EU-funded studies (REVERSE, ECRAID, COMBACTE) and coordinated the DRIVE-AB project to address this public health threat.

• Links
  • http://www.hug-ge.ch/sites/interhug/files/structures/maladies_infectieuses/documents/biosketch_s._harbarth.pdf
  • http://www.ncbi.nlm.nih.gov/pubmed?cmd=PureSearch&term=Harbarth%20S%5bAuthor%5d
  • http://www.combacte.com/
  • http://drive-ab.eu/
  • http://www.saturn-project.eu/
  • http://www.r-gnosis.eu/